McKesson Corp. (NYSE: MCK), San Francisco, CA, has agreed to acquire Vantage Oncology LLC, a provider of radiation oncology, medical oncology and integrated cancer care, and Biologics Inc., an oncology pharmacy services company. The combined transactions are valued at $1.2 billion.
Both Vantage and Biologics will become part of McKesson’s specialty health business. Collectively, these acquisitions will increase McKesson’s specialty pharmaceutical distribution scale, oncology-focused pharmacy offerings, solutions for manufacturers and payers, and scope of community-based oncology and practice management services available to providers and patients.